Guo Edward Ming - Net Worth and Insider Trading

Guo Edward Ming Net Worth

The estimated net worth of Guo Edward Ming is at least $5.2 Billion dollars as of 2025-07-19. Guo Edward Ming is the of Ascentage Pharma Group International and owns about 64,585,929 shares of Ascentage Pharma Group International (HKSE:06855) stock worth over $5.2 Billion. Details can be seen in Guo Edward Ming's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Guo Edward Ming has not made any transactions after 2023-10-27 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data
Unlimited Filters in All-in-One Stock Screener
Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Quick Customer Support
And Much More...

Transaction Summary of Guo Edward Ming

To

Guo Edward Ming Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Guo Edward Ming owns 1 companies in total, including Ascentage Pharma Group International (HKSE:06855) .

Click here to see the complete history of Guo Edward Ming’s form 4 insider trades.

Insider Ownership Summary of Guo Edward Ming

Ticker Company Transaction Date Type of Owner
HKSE:06855 Ascentage Pharma Group International 2023-10-27

Guo Edward Ming Latest Holdings Summary

Guo Edward Ming currently owns a total of 1 stock. Guo Edward Ming owns 64,585,929 shares of Ascentage Pharma Group International (HKSE:06855) as of October 27, 2023, with a value of $5.2 Billion.

Latest Holdings of Guo Edward Ming

Ticker Company Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
HKSE:06855 Ascentage Pharma Group International 2023-10-27 64,585,929 79.90 5,160,415,727

Holding Weightings of Guo Edward Ming


Guo Edward Ming Form 4 Trading Tracker

According to the SEC Form 4 filings, Guo Edward Ming has made a total of 10 transactions in Ascentage Pharma Group International (HKSE:06855) over the past 5 years, including 0 buys and 0 sells. The most-recent trade in Ascentage Pharma Group International is the sale of 0 shares on October 27, 2023, which brought Guo Edward Ming around $0.

Insider Trading History of Guo Edward Ming

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Guo Edward Ming Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Guo Edward Ming Ownership Network

Ownership Network List of Guo Edward Ming

No Data

Ownership Network Relation of Guo Edward Ming

Insider Network Chart


Guo Edward Ming Owned Company Details

What does Ascentage Pharma Group International do?

Who are the key executives at Ascentage Pharma Group International?

Guo Edward Ming is the of Ascentage Pharma Group International. Other key executives at Ascentage Pharma Group International include 2201 Interest of corporation controlled by you JPMorgan Chase & Co. , 2201 Interest of corporation controlled by you Takeda Pharmaceuticals Company Limited , and 2101 Beneficial owner Takeda Pharmaceuticals International AG .

Ascentage Pharma Group International (HKSE:06855) Insider Trades Summary

Over the past 18 months, Guo Edward Ming made no insider transaction in Ascentage Pharma Group International (HKSE:06855). Other recent insider transactions involving Ascentage Pharma Group International (HKSE:06855) include a net sale of 0 shares made by JPMorgan Chase & Co. , a net purchase of 24,307,322 shares made by Takeda Pharmaceuticals International AG , and a net purchase of 24,307,322 shares made by Takeda Pharmaceuticals Company Limited .

In summary, during the past 3 months, insiders sold 0 shares of Ascentage Pharma Group International (HKSE:06855) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Ascentage Pharma Group International (HKSE:06855) were sold and 48,614,644 shares were bought by its insiders, resulting in a net purchase of 48,614,644 shares.

Ascentage Pharma Group International (HKSE:06855)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Ascentage Pharma Group International Insider Transactions

No Available Data

Guo Edward Ming Mailing Address

Above is the net worth, insider trading, and ownership report for Guo Edward Ming. Currently GuruFocus does not have mailing address information for Guo Edward Ming.